Daniel J DeAngelo

60PUBLICATIONS
329CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Rheumatology and arthritisHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Sep 25, 2026
Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

|Aug 11, 2026
Optimizing safety and efficacy of asparaginase and blinatumomab therapy in frontline acute lymphoblastic leukemia regimens in diverse health care settings-international expert consensus.

|Jul 17, 2026
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia.

|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|Jun 04, 2026
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

Pageof 10

Frequent Collaborators

21 joint publications

Marlise R Luskin

15 joint publications

Jacqueline S Garcia

13 joint publications

Shai Shimony

9 joint publications

R Coleman Lindsley